Endurance Training Inhibits the JAK2/STAT3 Pathway to Alleviate Sarcopenia

被引:2
|
作者
Yao, Binyu [1 ]
Li, Lunyu [1 ]
Guan, Xiaotian [2 ]
Zhu, Junjie [3 ]
Liu, Qingsong [4 ]
Qu, Bo [1 ]
Ding, Haili [1 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Chengdu, Sichuan, Peoples R China
[2] Qionglai Hosp Tradit Chinese Med, Chengdu, Sichuan, Peoples R China
[3] Jiamusi Univ, Sch Phys Educ, Jiamusi, Heilongjiang, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Sarcopenia; Endurance training; Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3); Nuclear receptor subfamily 1; group D member 1 (Nr1d1); SENESCENCE-ACCELERATED MOUSE; REV-ERB-ALPHA; SKELETAL-MUSCLE; EXERCISE; ANTIOXIDANT; ATROPHY;
D O I
10.33549/physiolres.935234
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aging leads to a decrease in muscle function, mass, and strength in skeletal muscle of animals and humans. The transcriptome identified activation of the JAK/STAT pathway, a pathway that is associated with skeletal muscle atrophy, and endurance training has a significant effect on improving sarcopenia; however, the exact mechanism still requires further study. We investigated the effect of endurance training on sarcopenia. Six -month -old male SAMR1 mice were used as a young control group (group C), and the same month -old male SAMP8 mice were divided into an exercise group (group E) and a model group (group M). A 3 -month running exercise intervention was performed on group E, and the other two groups were kept normally. Aging caused significant signs of sarcopenia in the SAMP8 mice, and endurance training effectively improved muscle function, muscle mass, and muscle strength in the SAMP8 mice. The expression of JAK2/STAT3 pathway factor was decreased in group E compared with group M, and the expression of SOCS3, the target gene of STAT3, and NR1D1, an atrophy -related factor, was significantly increased. Endurance training significantly improved the phenotypes associated with sarcopenia, and the JAK2/STAT3 pathway is a possible mechanism for the improvement of sarcopenia by endurance training, while NR1D1 may be its potential target.
引用
收藏
页码:295 / 304
页数:10
相关论文
共 50 条
  • [1] Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
    Perrone, Giulia
    Calabrese, Elisabetta
    Hideshima, Teru
    Gorgun, Gullu
    Hiroshi, Ikeda
    Cristea, Diana
    Santo, Loredana
    Hu Yiguo
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 1113 - 1113
  • [2] Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
    Hu, Xue
    Jiao, Fangzhou
    Zhang, Lan
    Jiang, Yingan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Salidroside inhibits the ferroptosis to alleviate lung ischemia reperfusion injury via the JAK2/STAT3 signalling pathway
    Yu, Xiaobo
    Xu, Binbin
    Zhang, Mingdong
    Yao, Xuelian
    Xu, Kun
    Gao, Fengying
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 722
  • [4] FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
    Xujun Li
    Jiangyi Liu
    BMC Cancer, 23
  • [5] FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
    Li, Xujun
    Liu, Jiangyi
    BMC CANCER, 2023, 23 (01)
  • [6] Targeting the JAK2/STAT3 pathway in ovarian cancer
    Gritsina, Galina
    Xiao, Fang
    O'Brien, Shane W.
    Maglaty, Marisa A.
    Xu, Ren-Huan
    Sigal, Luis J.
    Litwin, Samuel
    Connolly, Denise C.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Tamoxifen inhibits astrocytic JAK2/STAT3 pathway in rats with traumatic spinal injury
    Wang, Jun
    Su, Ke
    Li, Long-Jie
    Ma, Shi-Yun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (06) : 1277 - 1283
  • [8] Ginkgetin Inhibits the Growth of Melanoma Cells by Regulating JAK2/STAT3 Signaling Pathway
    Zhuang, Chuchen
    Zhang, Liping
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2022, 20 (02) : 400 - 406
  • [9] Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway
    Ma, Xinglong
    Xu, Wenyuan
    Jin, Xinmeng
    Mu, Haoran
    Wang, Zhuoying
    Hua, Yingqi
    Cai, Zhengdong
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 942
  • [10] Schisandrin inhibits VSMCs proliferation and migration by arresting cell cycle and targeting JAK2 to regulating the JAK2/STAT3 pathway
    Huang, Qiuxia
    Liu, Xinyao
    Yu, Jinjin
    Liu, Yang
    Song, Huixin
    Zhang, Xinya
    Zhou, Lili
    Wang, Siqi
    Niu, Xiaofeng
    Li, Weifeng
    TISSUE & CELL, 2024, 89